Ibrutinib induced sensorimotor neuropathy: A novel side effect

---

Case Report

Author Details : Disha Tiwari, Dipanjan Panda*, Atul Sharma, Dewesh Kishan

Volume : 10, Issue : 2, Year : 2023

Article Page : 174-176

https://doi.org/10.18231/j.ijpo.2023.035

Suggest article by email

Get Permission

---

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a well-documented toxicity leading to dose limitation.Ibrutinib is an oral Bruton’s Tyrosine Kinase (BTK) inhibitor approved for treating chronic lymphocytic lymphoma. The most common neurological side effects of Ibrutinib include headache and dizziness. Herein, we report peripheral neuropathy as a dose-limiting manifestation of Ibrutinib treatment.

Keywords: Chemotherapy­induced, Ibrutinib, Sensorimotor neuropathy, CLL, Side effect.

How to cite : Tiwari D, Panda D, Sharma A, Kishan D, Ibrutinib induced sensorimotor neuropathy: A novel side effect. Indian J Pathol Oncol 2023;10(2):174-176

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.